Björn Cochlovius Email & Phone Number
Who is Björn Cochlovius? Overview
A concise factual answer block for searchers comparing this professional profile.
Björn Cochlovius is listed as - CEO at eleva GmbH- Ph.D., Assoc.Prof.- Opinions are my own. at eleva, based in Frankfurt, Hesse, Germany. AeroLeads shows a matched LinkedIn profile for Björn Cochlovius.
Björn Cochlovius previously worked as Chief Executive Officer at Eleva and Founder and Owner at Bc Biomed Consulting Gmbh. Björn Cochlovius holds Dipl.-Biol., Oncology / Molecular Biology from Universitat Des Saarlandes Medical School.
Email format at eleva
This section adds company-level context without repeating Björn Cochlovius's masked contact details.
Review company-level records connected to Björn Cochlovius before choosing the right outreach path.
About Björn Cochlovius
hello@elevabiologics.comSee: https://lnkd.in/e3uDUYDCBoard experience (including chairman), founder experience, CEO experience.Passionate healthcare professional combining strategic vision and business acumen with strong scientific and product development background. Experience with and understanding of the pharma and biotech scientific and Business Environment. Track record in building new entities (teams, departments, start-ups). Multilingual, accustomed to work in different cultural settings and across cultural borders. International mindset and global positions. Strong international Network, including Asia. Personal and professional Integrity. Ability to make Independent, analytical inquiries and desicions. Expertise in governance, strategy, Finance and funding, corporate and product development.
Listed skills include Biotechnology, Clinical Development, Oncology, Pharmaceutical Industry, and 46 others.
Björn Cochlovius's current company
Company context helps verify the profile and gives searchers a useful next step.
Björn Cochlovius work experience
A career timeline built from the work history available for this profile.
Founder And Owner
CurrentSupport of biotech companies regarding strategy, partnering, M&A, fundraising.Business Development for Atriva Therapeutics.
Co-Founder
CurrentAssociate Professor (Immunology)
CurrentTeaching immunology to medical students.
Chairman Of The Board
Chairman Of The Board
Chairman Of The Board
Non-Executive Board Director
Corporate Development Consultant (Part Time)
Corporate Development Team covering in/out-licensing, strategic partnerships, M&A.Major achievement: negotiated and closed a triple-digit mEUR contract, see below.
Senior Director Development Japan-Asia-Pacific
Responsibility for Development Strategy and its coordination on global and regional scale for all assets, all countries of Asia-Pacific. Large team (ca 125) in Tokyo.
Head Strategic Area Oncology
Building up from scratch a novel Oncology Department in Europe with global reach and own pipeline.
Co-Founder
Founder-CEO Aug 2011-Jan 2012; Chairman of the Board Jan 2012-May 2013Virtual biotech company focused on new therapies for Ciliopathies.
Director Business Development
- In-licensing of oncology-assets (preclinical up to clinical phase III): responsibility/project leadership from contact establishment to deal-signature: heading scientific/clinical review, due diligence and negotiation processes).- Support of/involvement in M&A and Roche Venture Fund activities.
Ceo
Virtual start-up company. Projects in Alzheimer's Disease, small molecule drugs. Reporting to Board of Directors.
Head R&D
Discovery and development of recombinant fully human antibodies for the therapy of cancer and viral infections. Reporting to CEO.
Director Preclinical Development
Restructuring of the company's previous focus (diagnostics, infectious diseases) to therapy and oncology. Building-up of a new R&D team. Reporting to CEO.
Department Head Recombinant Antibodies
In vitro and in vivo development of fully human recombinant bispecific antibodies (diabodies, tandem diabodies) for the therapy of rheumatoid arthritis and cancer.Reporting to Institute's Director (NOBEL LAUREATE Prof. Harald zur Hausen).
Guest Scientist (Embo Scholarship)
Development of recombinant cell-membrane anchored T-cell activating receptors.
Postdocoral Fellow / Senior Scientist
Co-developer of the novel bispecific antibody format "tandem diabodies": performing in vivo proof-of-concept experiments.
Björn Cochlovius education
Dipl.-Biol., Oncology / Molecular Biology
Dr.Rer.Nat. (Ph.D.) Magna Cum Laude, Oncology / Immunology / Molecular Biology
Dr.Rer.Nat., Biology / Biochemistry / Genetics
Frequently asked questions about Björn Cochlovius
Quick answers generated from the profile data available on this page.
What company does Björn Cochlovius work for?
Björn Cochlovius works for eleva.
What is Björn Cochlovius's role at eleva?
Björn Cochlovius is listed as - CEO at eleva GmbH- Ph.D., Assoc.Prof.- Opinions are my own. at eleva.
Where is Björn Cochlovius based?
Björn Cochlovius is based in Frankfurt, Hesse, Germany while working with eleva.
What companies has Björn Cochlovius worked for?
Björn Cochlovius has worked for Eleva, Bc Biomed Consulting Gmbh, Medraxa Therapeutics Gmbh, Ruprecht-Karls Universitat Heidelberg Medical Faculty, and Karolinska Development.
How can I contact Björn Cochlovius?
You can use AeroLeads to view verified contact signals for Björn Cochlovius at eleva, including work email, phone, and LinkedIn data when available.
What schools did Björn Cochlovius attend?
Björn Cochlovius holds Dipl.-Biol., Oncology / Molecular Biology from Universitat Des Saarlandes Medical School.
What skills is Björn Cochlovius known for?
Björn Cochlovius is listed with skills including Biotechnology, Clinical Development, Oncology, Pharmaceutical Industry, Clinical Trials, Immunology, Drug Development, and Strategy.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial